Shelter Pharma Ltd
Incorporated in 2007, Shelter Pharma Limited, is engaged in the business of manufacturing herbal products in Human Pharma and in Veterinary space.[1]
- Market Cap ₹ 62.4 Cr.
- Current Price ₹ 54.0
- High / Low ₹ 80.9 / 37.5
- Stock P/E 10.1
- Book Value ₹ 31.0
- Dividend Yield 0.00 %
- ROCE 51.1 %
- ROE 42.7 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 41.3%
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Debtor days have increased from 59.0 to 74.7 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2016 | Mar 2017 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|---|
| 28.09 | 29.95 | 30.07 | 22.48 | 30.06 | 36.15 | 40.02 | |
| 27.94 | 30.65 | 29.83 | 22.29 | 27.01 | 28.00 | 31.44 | |
| Operating Profit | 0.15 | -0.70 | 0.24 | 0.19 | 3.05 | 8.15 | 8.58 |
| OPM % | 0.53% | -2.34% | 0.80% | 0.85% | 10.15% | 22.54% | 21.44% |
| 0.00 | 0.83 | 0.01 | 0.01 | 0.00 | -0.07 | 0.00 | |
| Interest | 0.00 | 0.00 | 0.01 | 0.02 | 0.08 | 0.03 | 0.05 |
| Depreciation | 0.10 | 0.07 | 0.13 | 0.12 | 0.17 | 0.16 | 0.25 |
| Profit before tax | 0.05 | 0.06 | 0.11 | 0.06 | 2.80 | 7.89 | 8.28 |
| Tax % | 20.00% | 16.67% | 27.27% | 33.33% | 26.79% | 26.62% | 25.12% |
| 0.05 | 0.05 | 0.08 | 0.04 | 2.06 | 5.78 | 6.20 | |
| EPS in Rs | 1.10 | 1.10 | 1.76 | 0.83 | 42.56 | 7.46 | 5.36 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 21% |
| TTM: | 11% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 437% |
| TTM: | 6% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 41% |
| Last Year: | 43% |
Balance Sheet
Figures in Rs. Crores
| Mar 2016 | Mar 2017 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 0.45 | 0.45 | 0.45 | 0.48 | 0.48 | 7.74 | 11.56 |
| Reserves | 7.31 | 7.32 | 6.53 | 6.63 | 8.32 | 6.77 | 24.26 |
| 2.07 | 0.11 | 0.24 | 0.00 | 0.13 | 1.78 | 0.57 | |
| 1.73 | 3.76 | 3.41 | 3.09 | 3.91 | 5.16 | 1.52 | |
| Total Liabilities | 11.56 | 11.64 | 10.63 | 10.20 | 12.84 | 21.45 | 37.91 |
| 2.61 | 2.71 | 1.77 | 1.57 | 1.45 | 1.85 | 3.58 | |
| CWIP | 0.14 | 0.11 | 0.00 | 0.00 | 0.55 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.68 | 0.68 | 0.68 | 0.68 | 0.68 |
| 8.81 | 8.82 | 8.18 | 7.95 | 10.16 | 18.92 | 33.65 | |
| Total Assets | 11.56 | 11.64 | 10.63 | 10.20 | 12.84 | 21.45 | 37.91 |
Cash Flows
Figures in Rs. Crores
| Mar 2016 | Mar 2017 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|---|
| 0.00 | -0.27 | -0.28 | 0.52 | 0.00 | -1.85 | ||
| 0.00 | 0.29 | 0.03 | -0.85 | 0.11 | -4.54 | ||
| 0.00 | 0.00 | 0.48 | 0.06 | 0.21 | 11.01 | ||
| Net Cash Flow | 0.00 | 0.02 | 0.23 | -0.27 | 0.33 | 4.61 |
Ratios
Figures in Rs. Crores
| Mar 2016 | Mar 2017 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 12.99 | 14.14 | 7.40 | 12.34 | 19.55 | 82.69 | |
| Inventory Days | 61.39 | 49.67 | 55.59 | 69.41 | 80.06 | 110.22 | |
| Days Payable | 2.49 | 2.16 | 3.35 | 5.35 | 4.52 | 6.51 | |
| Cash Conversion Cycle | 71.89 | 61.65 | 59.64 | 76.40 | 95.09 | 186.41 | |
| Working Capital Days | 91.35 | 59.59 | 57.05 | 74.85 | 72.49 | 134.29 | |
| ROCE % | 0.68% | 1.12% | 35.91% | 63.36% |
Documents
Announcements
-
Compliance-Certificate Under Reg. 74 (5) Of SEBI (DP) Regulation, 2018.
8 Jul - Certificate for Non applicability of Regulation 74(5) of SEBI (DP) Regulation, 2018.
-
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
6 Jun - Shelter Pharma Limited secured order from Berlin International Medical Co for $ 1,20,000.
-
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
4 Jun - Shelter Pharma secured order from Genet International for Rupees 8.68 Lakhs ($ 10450) approximately.
- Non-Applicability Of Regulation 23(9) As Per Regulation 15 Of Chapter IV Of SEBI (LODR) Regulations, 2015 For The Half Year And Year Ended March 2024. 25 May
- Intimation Under Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015 Regarding Re-Appointment Of CA Mohammadaltaf Rasulbhai Sachora (ALTAF SACHORA & CO), FRN NO: 138017W Chartered Accountants As Internal Auditor 25 May
Annual reports
No data available.
Business Profile[1] Co. manufactures herbal medicines for veterinary, poultry, and human health care. Headquartered in Himmatnagar, Gujarat, their aim is to offer cost-effective and superior solutions to the health problems of humans and animals.